OnKure Therapeutics, Inc. OKUR Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $192.11M+225% | $59.05M-16.0% | $70.33M-15.6% | $83.37M-13.7% | $96.66M-12.7% | ||
| $5.38M+201% | $1.79M+49.7% | $1.2M+1.4% | $1.18M-22.0% | $1.51M-32.6% | ||
| $197.48M+225% | $60.84M-14.9% | $71.53M-15.4% | $84.55M-13.9% | $98.17M-13.1% | ||
| $519K-16.0% | $618K-14.2% | $720K-12.3% | $821K-11.2% | $925K-9.8% | ||
| $288K-25.6% | $387K-20.2% | $485K-16.5% | $581K-14.1% | $676K-12.2% | ||
| $405K+48.4% | $273K+163% | $104K-10.3% | $116K+6.4% | $109K0.0% | ||
| $198.69M+220% | $62.12M-14.7% | $72.84M-15.4% | $86.07M-13.8% | $99.88M-13.1% | ||
| $11.02M+669% | $1.43M+11.1% | $1.29M-45.8% | $2.38M+1.6% | $2.34M-21.0% | ||
| $409K-25.5% | $549K-3.2% | $567K+2.0% | $556K+1.8% | $546K+1.9% | ||
| $14.33M+142% | $5.92M-5.2% | $6.25M-17.8% | $7.6M-13.5% | $8.79M-16.6% | ||
| $409K-25.5% | $549K-20.1% | $687K-16.5% | $823K-13.8% | $955K-12.0% | ||
| $12K0.0% | $12K-70.0% | $40K0.0% | $40K0.0% | $40K— | ||
| $14.34M+142% | $5.93M-7.4% | $6.41M-18.9% | $7.9M-14.4% | $9.23M-16.7% | ||
| —— | —— | —— | —— | —— | ||
| $413.75M+53.0% | $270.42M+1.2% | $267.17M+1.1% | $264.2M+1.1% | $261.3M+1.1% | ||
| -$229.4M-7.1% | -$214.24M-6.7% | -$200.74M-7.9% | -$186.04M-9.0% | -$170.65M-10.3% | ||
| —— | —— | —— | —— | —— | ||
| $184.35M+228% | $56.18M-15.4% | $66.43M-15.0% | $78.17M-13.8% | $90.65M-12.7% | ||
| $198.69M+220% | $62.12M-14.7% | $72.84M-15.4% | $86.07M-13.8% | $99.88M-13.1% | ||
| $405K+48.4% | $273K+163% | $104K-10.3% | $116K+6.4% | $109K0.0% | ||
| $288K-25.6% | $387K-20.2% | $485K-16.5% | $581K-14.1% | $676K-12.2% | ||
| $288K-25.6% | $387K-20.2% | $485K-16.5% | $581K-14.1% | $676K-12.2% | ||
| $405K+48.4% | $273K+163% | $104K-10.3% | $116K+6.4% | $109K0.0% | ||
| $288K-25.6% | $387K-20.2% | $485K-16.5% | $581K-14.1% | $676K-12.2% | ||
| $405K+48.4% | $273K+163% | $104K-10.3% | $116K+6.4% | $109K0.0% | ||
| $2.9M-26.4% | $3.94M-10.3% | $4.39M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $409K-25.5% | $549K-20.1% | $687K-16.5% | $823K-13.8% | $955K-12.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are OnKure Therapeutics, Inc.'s total assets?
- OnKure Therapeutics, Inc. (OKUR) holds $198.7M in total assets, up 98.9% year over year.
- How much debt does OnKure Therapeutics, Inc. have?
- OnKure Therapeutics, Inc. carries $409.0K in total debt against $184.4M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does OnKure Therapeutics, Inc. have?
- OnKure Therapeutics, Inc. holds $192.1M in cash and equivalents.
- Can OnKure Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 13.78 — current assets exceed current liabilities.
- Where does OnKure Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from OnKure Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.